The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Author [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Karagergou, E., Dionyssopoulos A., Karayannopoulou M., Psalla D., Theodoridis A., Demiri E., et al. (2018).  Adipose-derived stromal vascular fraction aids epithelialisation and angiogenesis in an animal model.. J Wound Care. 27(10), 637-644.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Karkanaki, A., Piouka A., Katsikis I., Farmakiotis D., Macut D., & Panidis D. (2009).  Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients.. Fertil Steril. 92(6), 2078-81.
Toulis, K. A., Goulis D. G., Farmakiotis D., Georgopoulos N. A., Katsikis I., Tarlatzis B. C., et al. (2009).  Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.. Hum Reprod Update. 15(3), 297-307.
Polyzos, S. A., Kountouras J., & Zavos C. (2011).  Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas.. Int J Clin Pract. 65(3), 373-4.
Panagopoulou, P., Stamna E., Tsolkas G., Galli-Tsinopoulou A., Pavlitou-Tsiontsi E., Nousia-Arvanitakis S., et al. (2009).  Adiponectin gene polymorphisms in obese Greek youth.. J Pediatr Endocrinol Metab. 22(10), 955-9.
Polyzos, S. A., & Mantzoros C. S. (2016).  Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.. Metabolism. 65(9), 1297-306.
Polyzos, S. A., Kountouras J., & Zavos C. (2010).  Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis.. Hepatol Res. 40(4), 446-7.
Karras, S. N., Polyzos S. A., Tsekmekidou X., Gerou S., Gavana E., Papageorgiou V., et al. (2019).  Adiponectin and vitamin D-binding protein concentrations are independently associated in apparently healthy women but not men: a validation cohort.. Hormones (Athens). 18(1), 99-102.
Karras, S. N., Polyzos S. A., Newton D. A., Wagner C. L., Hollis B. W., van den Ouweland J., et al. (2018).  Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates.. Endocrine. 59(1), 164-174.
Panagopoulou, P., Galli-Tsinopoulou A., Fleva A., Pavlitou-Tsiontsi E., Vavatsi-Christaki N., & Nousia-Arvanitakis S. (2008).  Adiponectin and insulin resistance in childhood obesity.. J Pediatr Gastroenterol Nutr. 47(3), 356-62.
Panagopoulou, P., Fotoulaki M., Manolitsas A., Pavlitou-Tsiontsi E., Tsitouridis I., & Nousia-Arvanitakis S. (2008).  Adiponectin and body composition in cystic fibrosis.. J Cyst Fibros. 7(3), 244-51.
Anagnostis, P., Katsiki N., Athyros V. G., & Karagiannis A. (2014).  Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay.. Angiology.
Spanos, N., Tziomalos K., Macut D., Koiou E., Kandaraki E. A., Delkos D., et al. (2012).  Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.. Obes Facts. 5(4), 495-504.
Boutari, C., Tziomalos K., & Athyros V. G. (2016).  The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease.. Hippokratia. 20(4), 259-263.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2016).  Adipokines in nonalcoholic fatty liver disease.. Metabolism. 65(8), 1062-79.
Katsiki, N., Yovos J. G., Gotzamani-Psarrakou A., & Karamitsos D. T. (2011).  Adipokines and vascular risk in type 2 diabetes mellitus.. Angiology. 62(8), 601-4.
Savopoulos, C., Michalakis K., Apostolopoulou M., Miras A., & Hatzitolios A. (2011).  Adipokines and stroke: a review of the literature.. Maturitas. 70(4), 322-7.
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., Kostakis A., et al. (2012).  Adipokines: a novel link between adiposity and carotid plaque vulnerability.. Eur J Clin Invest. 42(12), 1278-86.
Comasco, E., Iliadis S. I., Larsson A., Olovsson M., Oreland L., Sundström-Poromaa I., et al. (2013).  Adipocytokines levels at delivery, functional variation of TFAP2β, and maternal and neonatal anthropometric parameters.. Obesity (Silver Spring). 21(10), 2130-7.
Petridou, E. Th, Dessypris N., Panagopoulou P., Sergentanis T. N., Mentis A-F. A., Pourtsidis A., et al. (2010).  Adipocytokines in relation to Hodgkin lymphoma in children.. Pediatr Blood Cancer. 54(2), 311-5.
Polyzos, S. A., Kountouras J., Zavos C., & Stergiopoulos C. (2010).  Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.. Med Hypotheses. 74(6), 1089-90.
Polyzos, S. A., Kountouras J., Papatheodorou A., Katsiki E., Patsiaoura K., Zafeiriadou E., et al. (2013).  Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.. Ann Hepatol. 12(5), 749-57.
Liakos, C. I., Papadopoulos D. P., & Kotsis V. T. (2017).  Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice. Am J Cardiovasc Drugs. 17(5), 391-398.
Buvat, J., Büttner H., Hatzimouratidis K., Vendeira P. A. S., Moncada I., Boehmer M., et al. (2013).  Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.. J Sex Med. 10(6), 1592-602.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.